Please login to the form below
Origins insights
This page shows the latest Origins insights news and features for those working in and with pharma, biotech and healthcare.
Bedrock Group rebrands as Resonant Group
Currently, the group includes Origins Insights – a health insights agency – and Bedrock Healthcare Communications, which has a ‘forward-thinking, audience-centred, creative approach to medical communications’. ... Both Origins Insights and
Latest news
-
The Communiqué Awards: what are judges looking for?
Entering awards that demand evidence and rigour is therefore a great way of building up your agency’s capabilities in presenting objectives, insights and the origins of your creative ideas. ... The objective here is to show that there are strategic
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
How Resonant’s innovation and creativity resolve healthcare communications challenges
There are now three businesses within the group, Bedrock Healthcare Communications, Origins Insights and our recent acquisition, Anthem PR. ... It’s a forward-thinking, audience-centred, creative approach to medical communications. Origins Insights.
-
A creative awakening – how pharma is bringing innovation to the patient journey
Having funky ideas and colourful imagery is not enough, but recent cognitive neuroscience insights shine a fascinating light on how creativity can be applied across the pharmaceutical sector. ... said Mark Corbett, chief innovation officer at Resonant
-
Harnessing the power of patient intelligence can redefine your success
Patient experience research. Origins Insights is expert in patient experience research and was the 2021 recipient of the BHBIA BOBI award for ‘Best Patient-Centric Approach’; we work to a philosophy ... To find out more about how Origins can redefine
-
Charting patient pathways with precision for better healthcare
The hope is that the approach will tap into a goldmine of insights that will prevent different elements of care grinding against each other like tectonic plates. ... Last month’s Patients as Partners Europe Conference examined the potency of patient
-
Patient diversity in clinical trials needs to be centre stage
the financial motives of the pharmaceutical industry, and/or disparities in the quality of care they receive.” By not involving more patients from relevant ethnic groups, industry restricts critical insights into ... Su Smith, Director of Origins
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Resonant Group appoints Stephen Marchant as chief development officer
Resonant Group – which includes Origins Insights and Bedrock Healthcare Communications – has appointed Stephen Marchant (pictured above) as chief development officer, a newly created role which will see him work to grow
-
Bedrock announces a number of new hires
She is set to support both Bedrock Healthcare communications and Origins Insights as part of her new role.
-
Bedrock Group bolsters team with three key appointments
Rounding out the new hires is Vicky O’Connor (pictured below, right), who joins Origins Insights – a Bedrock Group company – as strategic solutions director. ... As Origins Insights grows, our expert team of qualitative researchers and strategists
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Using ethnography to uncover the authentic patient experience
The way we do it at Origins Insights is very subtle, where the patient is in control. ... Su Smith is Director at Origins Insights. If you’d like to talk through how your patient insights could benefit from ethnography, please contact us.
-
Were patients at the heart of your New Year’s Resolutions?
Patients will always be at the heart of everything we do at Origins Insights.We deliver authentic patient insights that redefine success, working to uncover actionable patient-focused intelligence that make ... Contact us today to find out more:
-
RESONANT GROUP ACQUIRES PR BUSINESS
It will be renamed Anthem Public Relations and work alongside Resonant’s existing brands, Bedrock Healthcare Communications and Origins Insights. ... Origins Insights is an award-winning, pioneering health insights agency that delivers actionable,
-
Understanding the authentic patient experience can redefine the success of your clinical trial before you design it
Origins contribute to this changing attitude by helping our pharmaceutical and medical clients to understand the authentic patient experience. ... more insights and information: . 01252 240200. Address:. One Fleet. Ancells Road. Fleet. Hampshire. GU51 2UN
-
RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER
audiences. Origins Insights is an award-winning, pioneering health insights agency that delivers actionable, patient-focused intelligence to redefine success for our clients throughout the clinical development and marketing journey. ... www.origins-insigh
More from PMHub
Approximately 7 fully matching, plus 25 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
